Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 135,744 | 163,320 | 306,866 | 129,329 | 150,234 |
| Marketable Securities | 254,144 | 257,982 | 156,806 | 123,362 | 145,374 |
| Receivables | 14,049 | 10,673 | 10,496 | 10,653 | 9,193 |
| Inventories | 13,756 | 13,723 | 8,817 | 8,641 | 8,286 |
| Other current assets | 10,480 | 13,245 | 13,920 | 6,456 | 14,624 |
| TOTAL | $428,173 | $458,943 | $496,905 | $278,441 | $327,711 |
| Non-Current Assets | |||||
| PPE Net | 5,895 | 5,437 | 5,261 | 5,277 | 5,443 |
| Intangibles | 80,127 | 81,589 | 83,051 | 84,529 | 86,006 |
| Other Non-Current Assets | 13,742 | 13,952 | 14,033 | 14,920 | 14,960 |
| TOTAL | $99,764 | $100,978 | $102,345 | $104,726 | $106,409 |
| Total Assets | $527,937 | $559,921 | $599,250 | $383,167 | $434,120 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,573 | 10,372 | 10,216 | 5,711 | 7,936 |
| Accrued Expenses | 20,629 | 21,127 | 26,984 | 24,593 | 25,090 |
| Other current liabilities | 4,716 | 4,001 | 2,633 | 1,977 | 1,713 |
| TOTAL | $35,181 | $36,332 | $41,998 | $43,121 | $50,569 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 263 | 832 | 2,165 | 10,840 | 15,830 |
| Other Non-Current Liabilities | 13,728 | 13,898 | 14,248 | 14,558 | 14,909 |
| TOTAL | $13,728 | $13,898 | $14,248 | $14,558 | $14,909 |
| Total Liabilities | $48,909 | $50,230 | $56,246 | $57,679 | $65,478 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,599 | 101,509 | 101,074 | 93,901 | 93,032 |
| Common Shares | 102 | 101 | 101 | 94 | 93 |
| Retained earnings | -573,697 | -524,120 | -481,270 | -563,676 | -532,178 |
| Other shareholders' equity | 1,481 | 391 | 5 | -63 | -110 |
| TOTAL | $479,028 | $509,691 | $543,004 | $325,488 | $368,642 |
| Total Liabilities And Equity | $527,937 | $559,921 | $599,250 | $383,167 | $434,120 |